The MarketWatch News Department was not involved in the creation of this content. Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due ...
Findings highlight the advantages of Adolore's approach for the delivery of proprietary gene therapy directly to specialized pain-sensing peripheral nerves (nociceptors) that mediate profound ...
Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to hereditary neuronal sodium ion channel mutations Adolore’s Kv7 voltage-gated ...
In human genetic studies, it was found that activating Kv7 channel mutations can overcome severe chronic EM pain caused by hereditary neuronal sodium ion channel activating mutations DELRAY BEACH, FL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results